Literature DB >> 18384579

Incident physical disability in people with lower extremity peripheral arterial disease: the role of cardiovascular disease.

Jennifer S Brach1, Cam Solomon, Barbara L Naydeck, Kim Sutton-Tyrrell, Paul L Enright, Nancy Swords Jenny, Paulo M Chaves, Anne B Newman.   

Abstract

OBJECTIVES: To evaluate the risk of incident physical disability and the decline in gait speed over a 6-year follow-up associated with a low ankle-arm index (AAI) in older adults.
DESIGN: Observational cohort study.
SETTING: Forsyth County, North Carolina; Sacramento County, California; Washington County, Maryland; and Allegheny County, Pennsylvania. PARTICIPANTS: Four thousand seven hundred five older adults, 58% women and 17.6% black, participating in the Cardiovascular Health Study. MEASUREMENTS: AAI was measured in 1992/93 (baseline). Self-reported mobility, activity of daily living (ADL), and instrumental activity of daily living (IADL) disability and gait speed were recorded at baseline and at 1-year intervals over 6 years of follow-up. Mobility disability was defined as any difficulty walking half a mile and ADL and IADL disability was defined as any difficulty with 11 specific ADL and IADL tasks. Individuals with mobility, ADL, or IADL disability at baseline were excluded from the respective incident disability analyses.
RESULTS: Lower baseline AAI values were associated with increased risk of mobility disability and ADL/IADL disability. Clinical cardiovascular disease (CVD), diabetes mellitus, and interim CVD events partially explained these associations for mobility disability and clinical CVD and diabetes mellitus partially explained these associations for ADL and IADL disability. Individuals with an AAI less than 0.9 had on average a mean decrease in gait speed of 0.02 m/s per year, or a decline of 0.12 m/s over the 6-year follow-up. Prevalent CVD partly explained this decrease but interim CVD events did not further attenuate it.
CONCLUSION: Low AAI serves as marker of future disability risk. Reduction of disability risk in patients with a low AAI should consider cardiovascular comorbidity and the prevention of additional disabling CVD events.

Entities:  

Mesh:

Year:  2008        PMID: 18384579      PMCID: PMC4509641          DOI: 10.1111/j.1532-5415.2008.01719.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  34 in total

1.  Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease.

Authors:  M M McDermott; S Mehta; P Greenland
Journal:  Arch Intern Med       Date:  1999-02-22

2.  Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study.

Authors:  M M McDermott; L Fried; E Simonsick; S Ling; J M Guralnik
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

3.  Magnitude and patterns of decline in health and function in 1 year affect subsequent 5-year survival.

Authors:  Subashan Perera; Stephanie Studenski; Julie M Chandler; Jack M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-07       Impact factor: 6.053

Review 4.  The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys.

Authors:  F G Fowkes
Journal:  Int J Epidemiol       Date:  1988-06       Impact factor: 7.196

5.  Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial.

Authors:  A W Gardner; L I Katzel; J D Sorkin; D D Bradham; M C Hochberg; W R Flinn; A P Goldberg
Journal:  J Am Geriatr Soc       Date:  2001-06       Impact factor: 5.562

6.  Peripheral arterial disease detection, awareness, and treatment in primary care.

Authors:  A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

7.  Improved functional outcomes following exercise rehabilitation in patients with intermittent claudication.

Authors:  A W Gardner; L I Katzel; J D Sorkin; L A Killewich; A Ryan; W R Flinn; A P Goldberg
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-10       Impact factor: 6.053

8.  Body mass index, weight change, and risk of mobility disability in middle-aged and older women. The epidemiologic follow-up study of NHANES I.

Authors:  L J Launer; T Harris; C Rumpel; J Madans
Journal:  JAMA       Date:  1994-04-13       Impact factor: 56.272

9.  Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

Authors:  Mary McGrae McDermott; Kiang Liu; Philip Greenland; Jack M Guralnik; Michael H Criqui; Cheeling Chan; William H Pearce; Joseph R Schneider; Luigi Ferrucci; Lillian Celic; Lloyd M Taylor; Ed Vonesh; Gary J Martin; Elizabeth Clark
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

10.  Statin use and functional decline in patients with and without peripheral arterial disease.

Authors:  Jay Giri; Mary M McDermott; Philip Greenland; Jack M Guralnik; Michael H Criqui; Kiang Liu; Luigi Ferrucci; David Green; Joseph R Schneider; Lu Tian
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094

View more
  11 in total

1.  Relationship Between Chronic Conditions and Disability in African American Men and Women.

Authors:  Roland J Thorpe; Anastasia J Wynn; Janiece L Walker; Jenny R Smolen; Michael P Cary; Sarah L Szanton; Keith E Whitfield
Journal:  J Natl Med Assoc       Date:  2016-02       Impact factor: 1.798

2.  Transcranial Doppler and Lower Extremity Function in Older Adults: Einstein Aging Study.

Authors:  Ali Ezzati; Tatjana Rundek; Joe Verghese; Carol A Derby
Journal:  J Am Geriatr Soc       Date:  2017-11-11       Impact factor: 5.562

3.  Atherosclerosis and physical functioning in older men, a longitudinal study.

Authors:  M E M den Ouden; M J Schuurmans; I E M A Arts; D E Grobbee; M L Bots; A W van den Beld; S W J Lamberts; Y T van der Schouw
Journal:  J Nutr Health Aging       Date:  2013-01       Impact factor: 4.075

4.  Purpose in life is associated with a reduced risk of incident disability among community-dwelling older persons.

Authors:  Patricia A Boyle; Aron S Buchman; David A Bennett
Journal:  Am J Geriatr Psychiatry       Date:  2010-12       Impact factor: 4.105

5.  Arterial stiffness and gait speed in older adults with and without peripheral arterial disease.

Authors:  Nora L Watson; Kim Sutton-Tyrrell; Ada O Youk; Robert M Boudreau; Rachel H Mackey; Eleanor M Simonsick; Caterina Rosano; Susan E Hardy; B Gwen Windham; Tamara B Harris; Samer S Najjar; Edward G Lakatta; Hal H Atkinson; Karen C Johnson; Douglas C Bauer; Anne B Newman; Anne B Nemwan
Journal:  Am J Hypertens       Date:  2010-09-09       Impact factor: 2.689

6.  Subclinical vascular disease burden and longer survival.

Authors:  Michelle C Odden; Laura M Yee; Alice M Arnold; Jason L Sanders; Calvin Hirsch; Christopher deFilippi; Jorge R Kizer; Marco Inzitari; Anne B Newman
Journal:  J Am Geriatr Soc       Date:  2014-09       Impact factor: 5.562

7.  The AMC linear disability score (ALDS): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease.

Authors:  Rosemarie Met; Jim A Reekers; Mark J W Koelemay; Dink A Legemate; Rob J de Haan
Journal:  Health Qual Life Outcomes       Date:  2009-10-12       Impact factor: 3.186

8.  Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Authors:  Andrew D Althouse; J Dawn Abbott; Kim Sutton-Tyrrell; Alan D Forker; Manuel S Lombardero; L Virginia Buitrón; Ivan Pena-Sing; Jean-Claude Tardif; Maria Mori Brooks
Journal:  Diabetes Care       Date:  2013-06-04       Impact factor: 19.112

9.  Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial.

Authors:  Andrew D Althouse; J Dawn Abbott; Alan D Forker; Marnie Bertolet; Emma Barinas-Mitchell; Rebecca C Thurston; Suresh Mulukutla; Victor Aboyans; Maria Mori Brooks
Journal:  Diabetes Care       Date:  2014-03-04       Impact factor: 19.112

10.  Trajectories of the Framingham general cardiovascular risk profile in midlife and poor motor function later in life: the Whitehall II study.

Authors:  Alexis Elbaz; Martin J Shipley; Hermann Nabi; Eric J Brunner; Mika Kivimaki; Archana Singh-Manoux
Journal:  Int J Cardiol       Date:  2013-12-29       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.